The AI-Powered Platform That Keeps Trials in Sync
Every aspect of your clinical trial is connected; your technology should be too. The Medidata Platform unifies the entire trial lifecycle, from design to closeout, in a single AI-driven ecosystem. When conditions shift, your forecasts, plans, and workflows adapt in real time.
Powering the Medidata Platform, our clinically-fluent AI™ simulates outcomes, predicts risks before they surface, and turns signals into actions your teams can take with confidence.
Sign up for Medidata Plus for full access to the Al-layer of the Medidata Platform.
The Proven Platform for Trial Success
The platform that supported 80% of all FDA novel drug approvals in 2025, put to work on your trials. One partner to simplify complexity, embed AI into execution, and scale globally.
One Architecture
Your teams operate on one data foundation, one governance framework, and one security and compliance model, eliminating silos that fragment your workflows and slow trials down.
Embedded AI
Trained on validated data from 38K+ trials and 12M+ patients, our AI, Dot, doesn't just surface signals: it simulates outcomes and recommends next best actions, accelerating every stage of your study.
Built for Global Scale
Therapeutic development starts long before your first patient enrolls and continues well beyond database lock.
As part of Dassault Systèmes, Medidata is part of an end-to-end life sciences and healthcare platform spanning research and discovery to manufacturing and delivery. Your trials gain the advantage of intelligence that strengthens every stage of the process.
All Your Workflows on One Platform
Point solutions can’t keep up with the complexity of modern trials. By bringing your study, patient and data workflows together on one platform, every data point becomes traceable and decisions stop being made in silos.
Explore how the Medidata Study, Patient and Data Experiences connect across your entire trial lifecycle, streamlining operations and enhancing study success.
What Sponsors, CROs, and Sites Say
Reducing Burdens for Sites:
Medidata’s Single Platform
“The full suite of solutions within one platform was the draw for us. We wouldn’t have the complaint [from site partners], ‘I’m a site in a trial and I have to log into 10 different systems and platforms, and each vendor has its own system with a different login and password.’ That’s too complicated for our sites. We minimize the number of platforms that we use for a study—one login, maybe two—reducing complexity and improving usability for sites so that they want to continue to work with us.”
Christina Villar
Head of Clinical Affairs
The Importance of Speed in Consolidating Data in Rare Disease Studies
“[Sponsors in the rare disease or biotech space] need cutting edge [solutions] that can adapt to extremely complicated [clinical trials]. The challenges are unique—the patient population is much smaller, but, within the volume of data that you’re collecting, each piece of data that comes in is all the more critical. [Medidata] can consolidate that data into a single platform that analyzes it quickly and can help pivot to changing strategies for a particular clinical program. This is very important.”
Kathy Zheng
Director Project Management and Clinical Innovations
Transitioning to Medidata Has Improved the Quality of Data
“The transition over to the Medidata Platform has enabled us to follow the provenance of data, from point of collection all the way to monitoring, tracking, and reporting, in a way that we weren’t able to do before.
We’ve been able to improve the quality of the data that we’ve been getting out of studies.”
Jay Jantz
Director of Clinical Data Analytics
Awards and Recognition
2026
Everest Group’s 2026 AI Innovation Watch: A Definitive Guide for Clinical Leaders
2025
Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025
2025
Medidata x Cogstate Partnership
Best Clinical Trial Technology Solution Provider
2024
IDC MarketScape Worldwide Life Science R&D DCT Technology Solutions and Consulting Services
2023 & 2024
Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms
2022 & 2023
Everest Group Decentralized Clinical Trial Platforms
FAQ
How does Medidata’s unified platform help CROs streamline study execution across multiple sponsors?
Medidata provides a consistent data architecture and standardized workflows across sponsors. CROs reduce system switching, duplicate builds, and manual reconciliation—while maintaining sponsor-specific controls, visibility, and governance.
How does the Medidata Platform compare to other clinical trial management platforms?
Many platforms connect point solutions. Medidata operates as an integrated ecosystem—data capture, CTMS, safety, payments, analytics, and AI within one governed environment. The result: less fragmentation, stronger traceability, and more predictable execution.
